Concepedia

Guru Sonpavde

GS

262

Publications

16K

Citations

64

H-Index

2006

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

University of Alabama at Birmingham

Harvard University

Baylor College of Medicine

Icahn School of Medicine at Mount Sinai

Guru Sonpavde is an author at Dana-Farber Cancer Institute specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

2006–2024

262

Publications

262

Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text

Prostate Cancer, Version 1.2016

James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson et al. · Journal of the National Comprehensive Cancer Network · 2016 · 650 citations

, , +14

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal et al. · Journal of the National Comprehensive Cancer Network · 2017 · 573 citations · Full text

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients

Guillermo de Velasco, Youjin Je, Dominick Bossé et al. · Cancer Immunology Research · 2017 · 459 citations · Full text

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles et al. · New England Journal of Medicine · 2023 · 421 citations · Full text

Rows per page

1–5 of 262